Determination of clopidogrel active metabolite to predict individual platelet aggregation function
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Poster
- By: RAY, Chin-Ying (Taoyuan, China)
- Co-author(s): Lin, Tzuyu (Chang Gung Memorial Hospital, Taoyuan, China Taiwan)
Chen, Hu (Chang Gung Memorial Hospital, Taoyuan, China Taiwan)
Deng, Shin Tarng (Chang Gung Memorial Hospital, Taoyuan, China Taiwan)
Background: Clopidogrel is an inactive prodrug requiring metabolization by the hepatic CYP450 system for its antiplatelet activity. Genetic and pharmacokinetic factors contribute to this wide variability in response.
Aims:The aim of this study was to determine the serum clopidogrel active metabolite(CAM) concentration to evaluate the antiplatelet.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.